BIPSO further strengthens environmental protection BIPSO sets the course for sterile contrast media production according to the latest environmental standards.

FDA approves Gadopiclenol injection for the U.S. market Bracco Announces FDA Approval of Gadopiclenol Injection, a New Macrocyclic High-Relaxivity Gadolinium-Based Contrast Agent which will be commercialized as VUEWAY™ (gadopiclenol) injection and VUEWAY™ (gadopiclenol) Pharmacy Bulk Package by Bracco.

Distributors list Distributors list

Iomeron 400 Iomeron® is a tri-iodinated non-ionic monomeric contrast medium for radiology.

CT Exprès CT Exprès™ Contrast Media Delivery System.

Empower CTA+ Efficiency and Control at your fingertips.

Contrast Induced Nephropathy Contrast Induced Nephropathy

Data protection Data Protection

Cookie Policy Cookie Policy

Search Search